Publications by authors named "Pascal Wolter"

Claim this Profile
D
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients.
Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Pascal Wolter

J Pers Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Youn H Kim, H Miles Prince, Sean Whittaker, Steven M Horwitz, Madeleine Duvic, Pascal Wolter

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.
Katja N De Paepe, Ciska-Anne Van Keerberghen, Giorgio M Agazzi, Frederik De Keyzer, Olivier Gheysens, Pascal Wolter

Radiol Imaging Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
Reinhard Dummer, Henry M Prince, Sean Whittaker, Steven M Horwitz, Youn H Kim, Pascal Wolter

Eur J Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome.
Vivien Marasigan, Canan Güvenç, Joost J van den Oord, Marguerite Stas, Veerle Boecxstaens, Pascal Wolter

Melanoma Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solar Lentigines are Associated with Better Outcome in Cutaneous Melanoma.
Vivien Marasigan, Canan Güvenç, Joost J Oord, Marguerite Stas, Veerle Boecxstaens, Pascal Wolter

Acta Derm Venereol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies.
Julie Bastin, Emilie Werbrouck, Annelies Verbiest, Kevin Punie, Oliver Bechter, Pascal Wolter

Acta Clin Belg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib.
Emilie Werbrouck, Julie Bastin, Diether Lambrechts, Annelies Verbiest, Thomas Van Brussel, Pascal Wolter

Acta Clin Belg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib.
Maxime Vanmechelen, Diether Lambrechts, Thomas Van Brussel, Annelies Verbiest, Gabrielle Couchy, Pascal Wolter

Clin Genitourin Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
Katja N De Paepe, Frederik De Keyzer, Pascal Wolter, Oliver Bechter, Daan Dierickx

J Magn Reson Imaging· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.
Matteo S Carlino, Georgina V Long, Dirk Schadendorf, Caroline Robert, Antoni Ribas, Pascal Wolter

Eur J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.
Paolo A Ascierto, Lars Bastholt, Pier F Ferrucci, Johan Hansson, Iván Márquez Rodas, Pascal Wolter

Melanoma Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Minimal Residual Disease-Directed Therapy in Melanoma.
Florian Rambow, Aljosja Rogiers, Oskar Marin-Bejar, Sara Aibar, Julia Femel, Pascal Wolter

Cell· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
Richard D Carvajal, Sophie Piperno-Neumann, Ellen Kapiteijn, Paul B Chapman, Stephen Frank, Pascal Wolter

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.
Mario Sznol, Pier Francesco Ferrucci, David Hogg, Michael B Atkins, Pascal Wolter

J Clin Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE.
Aljosja Rogiers, Sara Vander Borght, Krizia Tuand, Pascal Wolter, Marguerite Stas

Melanoma Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
H Miles Prince, Youn H Kim, Steven M Horwitz, Reinhard Dummer, Julia Scarisbrick, Pascal Wolter

Lancet· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination.
Aljosja Rogiers, Pascal Wolter, Oliver Bechter

Melanoma Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Severe Acute Cardiac Failure on Sunitinib After Left-Sided Thoracal Radiation Therapy.
Ciska-Anne Van Keerberghen, Simon Van Wambeke, Pascal Wolter, Patrick Schöffski, Johan Van Cleemput

Clin Genitourin Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Anne Sacré, Philippe Barthélémy, Clement Korenbaum, Mickael Burgy, Pascal Wolter

Acta Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Visualization of the Antiangiogenic Effects of Sunitinib During the Treatment of Metastatic Clear Cell Renal Cell Carcinoma.
Ciska-Anne Van Keerberghen, Johnny Jean-Baptiste, Pascal Wolter, Jessica Zucman-Rossi, Patrick Schöffski

Clin Genitourin Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Jean Jacques Grob, Mayur M Amonkar, Boguslawa Karaszewska, Jacob Schachter, Reinhard Dummer, Pascal Wolter

Lancet Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.
Aljosja Rogiers, Joost J van den Oord, Marjan Garmyn, Marguerite Stas, Cindy Kenis, Pascal Wolter

Drugs Aging· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
Jérémie Nsengimana, Jon Laye, Anastasia Filia, Christy Walker, Rosalyn Jewell, Pascal Wolter

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in acute kidney injury in a patient with breast cancer: a case report.
Francesca Donders, Dirk Kuypers, Pascal Wolter, Patrick Neven

J Med Case Rep· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis